glucagon-like peptide-1 news - Search News

How to preserve muscle mass on weight-loss drugs like Wegovy

There is some debate as to whether GLP-1 agonist drugs like Wegovy can lead to unhealthy muscle mass loss in addition to general weight loss. Is this a real concern, and if so, how can a person maintain their muscle mass on GLP-1 drugs?

Hosted on MSN · 9h

Wegovy costs $1,349 in the US vs. $92 in the UK. Why are weight loss drugs so pricey?

About 42% of U.S. adults are obese, the CDC says. GLP-1 medications have changed the picture for people hoping to reduce risks with obesity.

The Guardian on MSN · 1d

Weight-loss drugs can improve kidney health, study finds

Weight-loss drugs can reduce the risk of worsening kidney function, kidney failure and dying from kidney disease by a fifth, according to a study. Glucagon-like peptide-1 (GLP-1) receptor agonists are a family of medications that help people shed the pounds,

The Hans India · 1d

Weight loss, diabetes drugs can also protect kidneys: Study

The popular glucagon-like peptide-1 (GLP-1) receptor agonists known to help in weight loss as well as manage blood sugar can also protect the kidneys, regardless of diabetes status, finds a study

The Independent on MSN · 1d

Popular diabetes and obesity drugs also protect kidneys, study suggests

Popular diabetes and obesity drugs also protect kidneys, study suggests - The combined reduction in the risk of kidney failure, worsening kidney function and death due to kidney disease was 19%, researchers found.

Semaglutide Rocketing Past Statins as Millions Eligible

A new study suggests that 40% of American adults have conditions that could benefit from semaglutide treatment.

15hon MSN

Cheap Ozempic? How millions of Americans with obesity may get access to costly weight-loss drugs

Millions of obese Americans would get access to popular weekly injectables that would help them shed pounds quickly if a $35 ...

12h

What's Next for Amgen Obesity Drug After Investors Disappointed by Results

Shares in Amgen fell on Tuesday after they announced the results of a trial for their weight loss drug MariTide.

GLP-1 Labels Don’t Reflect Trial Exclusions

Clinicians are advised to screen patients for conditions that would have rendered them ineligible to participate in the ...

McKnight's Long-Term Care News1d

White House eyes plan to cover anti-obesity drugs for people on Medicare, Medicaid

The Biden administration has proposed a new plan to expand coverage of glucagon-like peptide-1 (GLP-1) medications such ...

17hon MSN

Biden wants Medicare, Medicaid to cover pricey weight loss drugs such as Wegovy

The Biden administration wants to expand coverage of anti-obesity medications to millions on Medicare, Medicaid.

Thanksgiving on Ozempic: Here’s how to enjoy the meal with a smaller appetite

GLP-1 (glucagon-like peptide-1) medications reduce appetite by sending signals of fullness to the brain and slowing down ...

Glucagon-like peptide-1 receptor agonists for treating chronic kidney disease in patients with type 2 diabetes

In a randomized controlled trial of people with type 2 diabetes, albuminuria, and estimated glomerular filtration rate (eGFR) ...

Wegovy, Mounjaro: Suffolk County issues new guidelines for access to costly weight-loss drugs

Those on the medications, known as GLP-1s or glucagon-like peptide-1, will additionally weigh in four times a month on ...

News Medical on MSN7d

Impact of glucagon-like peptide-1 receptor agonists on alcohol consumption

The impact of GLP-1 RAs on alcohol use is explored, showing potential benefits in reducing intake and cravings, but with ...

Some results have been hidden because they may be inaccessible to you

Show inaccessible results